Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 11/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.57 |
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6291931 | 0.94 | GSK3B (0.89) | GSK3BPTPN1CA1CA2RAB9A | |
| SCHEMBL2810270 | 0.85 | GSK3B (0.73) | GSK3BRAB9AALDH1A1MAPT | |
| Benzonitrile SCHEMBL28107145 | 0.83 | GSK3B (0.70) | GSK3BPTPN1RAB9AALDH1A1MAPT | |
| SCHEMBL11983785 | 0.83 | GSK3B (0.70) | GSK3BCA1CA2RAB9AALDH1A1 | |
| SCHEMBL205280 | 0.82 | GSK3B (0.80) | GSK3BPTPN1RAB9A | |
| SCHEMBL319223 | 0.81 | GSK3B (0.68) | GSK3BCA1CA2RAB9AALDH1A1 | |
| SCHEMBL1657827 | 0.79 | GSK3B (0.66) | GSK3BCA1CA2RAB9AALDH1A1 | |
| SCHEMBL311121 | 0.79 | GSK3B (0.66) | GSK3BCA1CA2RAB9AALDH1A1 | |
| SCHEMBL13545641 | 0.79 | GSK3B (0.66) | GSK3BCA1CA2RAB9AALDH1A1 | |
| SCHEMBL1146988 | 0.79 | RAB9A (0.71) | GSK3BCA1CA2RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118908954-A | Chemical-enzymatic process synthesis method of isaconazole | 浙江工业大学 | 2024-11-08 | — | — | CN | claimed |
| CN-116102524-B | Asymmetric synthesis method of beta-amino alcohol compound | 华东理工大学 | 2024-10-01 | — | — | CN | claimed |
| CN-118666831-A | Synthesis method of isaconazole sulfate intermediate impurity | 成都天兴致远生物科技有限公司 | 2024-09-20 | — | — | CN | claimed |
| EP-3959200-B1 | NEW TRIAZOLE AND TRIAZOLOTHIADIAZINE DERIVATIVES EXERTING CYTOTOXIC AND APOPTOTIC EFFECTS ON A549 CELLS THROUGH AKT INHIBITION | ANADOLU UNIV (TR) | 2024-03-20 | — | — | EP | claimed |
| US-20240010644-A1 | PROCESS FOR THE PREPARATION OF ISAVUCONAZONIUM SULFATE | CITIBANK, N.A. | 2024-01-11 | — | — | US | claimed |
| EP-3958980-B1 | TARGETED NOVEL TRIAZOLOTHIADIAZINE DERIVATIVES FOR THE TREATMENT OF LUNG CANCER | ANADOLU UNIV (TR) | 2023-11-15 | — | — | EP | claimed |
| CN-116217501-A | Method for efficiently synthesizing nitrogen-containing heterocyclic compound | 东华理工大学 | 2023-06-06 | — | — | CN | claimed |
| EP-3959200-A1 | NEW TRIAZOLE AND TRIAZOLOTHIADIAZINE DERIVATIVES EXERTING CYTOTOXIC AND APOPTOTIC EFFECTS ON A549 CELLS THROUGH AKT INHIBITION | Anadolu Universitesi (TR) | 2022-03-02 | — | — | EP | claimed |
| EP-3958980-A1 | TARGETED NOVEL TRIAZOLOTHIADIAZINE DERIVATIVES FOR THE TREATMENT OF LUNG CANCER | Anadolu Universitesi (TR) | 2022-03-02 | — | — | EP | claimed |
| WO-2022005414-A1 | NEW TRIAZOLE AND TRIAZOLOTHIADIAZINE DERIVATIVES EXERTING CYTOTOXIC AND APOPTOTIC EFFECTS ON A549 CELLS THROUGH AKT INHIBITION | ANADOLU UNIVERSITESI (TR) | 2022-01-06 | — | — | WO | claimed |
| EP-1954264-A2 | PROCESS FOR THE MANUFACTURE OF EPOXYBUTANOL INTERMEDIATES | Basilea Pharmaceutica AG (CH) | 2008-08-13 | — | — | EP | claimed |
| WO-2007062542-A2 | PROCESS FOR THE MANUFACTURE OF EPOXYBUTANOL INTERMEDIATES | BASILEA PHARMACEUTICA AG (CH) | 2007-06-07 | — | — | WO | claimed |
| EP-1745045-A2 | NOVEL DICATIONIC IMIDAZO 1,2-a PYRIDINES AND 5,6,7,8-TE TRAHYDRO-IMIDAZO 1,2a PYRIDINES AS ANTIPROTOZOAL AGENTS | The University of North Carolina at Chapel Hill (US) | 2007-01-24 | — | — | EP | claimed |
| US-20050282853-A1 | Novel dicationic imidazo[1,2-a]pyridines and 5,6,7,8,-tetrahydro-imidazo[1,2,-a]pyridines as antiprotozoal agents | BOYKIN DAVID W | 2005-12-22 | — | — | US | claimed |
| WO-2005086808-A2 | NOVEL DICATIONIC IMIDAZO[1,2-a]PYRIDINES AND 5,6,7,8-TETRAHYDRO-IMIDAZO[1,2a]PYRIDINES AS ANTIPROTOZOAL AGENTS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2005-09-22 | — | — | WO | claimed |
| US-20040176432-A1 | Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives | BASILEA PHARMACEUTICA AG (CH) | 2004-09-09 | — | — | US | claimed |
| EP-1399402-A1 | INTERMEDIATE HALOPHENYL DERIVATIVES AND THEIR USE IN A PROCESS FOR PREPARING AZOLE DERIVATIVES | Basilea Pharmaceutica AG (CH) | 2004-03-24 | — | — | EP | claimed |
| WO-2003002498-A1 | INTERMEDIATE HALOPHENYL DERIVATIVES AND THEIR USE IN A PROCESS FOR PREPARING AZOLE DERIVATIVES | BASILEA PHARMACEUTICA AG (CH) | 2003-01-09 | — | — | WO | claimed |
| US-6300353-B1 | FOR THERAPY OF FUNGAL INFECTIONS | BASILEA PHARMACEUTICA AG, A SWISS COMPANY (CH) | 2001-10-09 | — | — | US | claimed |
| WO-1999045008-A1 | 3-[4-(4-CYANOPHENYL)THIAZOL-2-Y)]-1-(1H-1,2,4-TRIAZOL-1-YL)-BUTAN-2-OL DERIVATIVES HAVING ANTIFUNGAL ACTIVITY | F. HOFFMANN-LA ROCHE AG (CH) | 1999-09-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050282853-A1 | Novel dicationic imidazo[1,2-a]pyridines and 5,6,7,8,-tetrahydro-imidazo[1,2,-a]pyridines as antiprotozoal agents | PBRM1, QDPR, DHPS | GSK3B 4819/4885PTPN1 2973/4885CA1 3509/4885 |
| US-20240010644-A1 | PROCESS FOR THE PREPARATION OF ISAVUCONAZONIUM SULFATE | STS, MPST, SULT1A1 | GSK3B 1657/4885PTPN1 4109/4885CA1 2028/4885 |
| US-20040176432-A1 | Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives | CYP51A1, MALT1, CYP7A1 | GSK3B 2119/4885PTPN1 833/4885CA1 411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.